These findings indicate that ELISA-based anti-FGFR3 are not specific for sensory neuropathies and could occur in other conditions, but most certainly could also be due to false-positive ELISA results when no confirmation method such as tissue-based assay is applied. This evidence concerns the gene FGFR3 and Sensory neuropathy.